Abstract:Lung cancer is a well-known malignant tumor of the respiratory tract, which has caused a significant level of damage to human health. Micro-RNAs (miRNAs) are tiny, non-coding RNA stem-loop structures with a length of roughly 2025 nucleotides that function as powerful modulators of mRNA and protein products of a gene. miRNAs may modulate many biological processes involving growth, differentiation, proliferation, and cell death and play a key role in the pathogenesis of various types of malignancies. Several accumulating pieces of evidence have proven that miRNA, especially miR-146a, are crucial modulators of innate immune response sequences. A novel and exciting cancer research field has involved miRNA for the detection and suppression of cancer. However, the actual mechanism which is adopted by these miRNA is still unclear. miRNAs have been used as a cancer-associated biomarker in several studies, suggesting their altered expression in various cancers compared to the normal cells. The amount of expression of miRNA can also be used to determine the stage of the disease, aiding in early detection. In breast, pancreatic, and hepatocellular carcinoma, and gastric cancer, cancer cell proliferation and metastasis has been suppressed by miR-146a. Changes in miR-146a expression levels have biomarker importance and possess a high potential as a therapeutic target in lung cancer. It retards epithelial-mesenchymal transition and promotes the therapeutic action of anticancer agents in lung cancer. Studies have also suggested that miR-146a affects gene expression through different signaling pathways viz: TNF-, NF-B and MEK-1/2, and JNK-1/2. Further research is required for understanding the molecular mechanisms of miR-146a in lung cancer. The potential role of miR-146a as a diagnostic marker of lung cancer must also be analyzed. This review summarizes the tumor-suppressing, anti-inflammatory, and antichemoresistive nature of miR-146a in lung cancer.

miR-137: a potential therapeutic target for lung cancer

MicroRNA-targeted therapeutics for lung cancer treatment

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?

Microrna-137 Inhibits Tumor Growth And Sensitizes Chemosensitivity To Paclitaxel And Cisplatin In Lung Cancer

Microrna-187 Inhibits Pten Expression And Promotes Cell Proliferation In Non-Small-Cell Lung Cancer

MiRNA-based therapeutic strategy in lung cancer.

Microrna-137 Modulates Pancreatic Cancer Cells Tumor Growth, Invasion and Sensitivity to Chemotherapy.

Therapeutic Role of MiR-140-5p for the Treatment of Non-small Cell Lung Cancer.

microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18

MiR-136-5p in cancer: Roles, mechanisms, and chemotherapy resistance

MicroRNA‑126: A New and Promising Player in Lung Cancer (Review)

Pathophysiology of miR-146a in lung cancer. Prospects of rising of efficiency of targeted therapy

Research Progress on Lung Cancer Related MicroRNAs

Research Progress on Lung Cancer Therapy and the Mechanism of MicroRNA in Lung Cancer and Its Drug Resistance

The Molecular Mechanisms and Therapeutic Potential of Microrna-7 in Cancer

Molecular Mechanisms and Roles of MiR-136-5p in Human Cancer and Other Disorders

Research progress on the relationship between lung cancer drug-resistance and microRNAs

Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung Cancer

MicroRNAs modulation in lung cancer: exploring dual mechanisms and clinical prospects

Roles of Microrna in Diagnosis, Therapy and Prognosis of Lung Cancer